23andMe has officially filed for Chapter 11 bankruptcy protection, which means a new company could acquire its genetic database. DNA data is particularly sensitive, and bad actors can use it to carry ...

CHARLOTTE, N.C. — Popular genetics company 23andMe, known for its at-home DNA testing kits, has filed for Chapter 11 bankruptcy, raising concerns about the safety of user data. The company, which ...

A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by its former CEO Anne Wojcicki, effectively putting her back in control of the bankrupt genetics company. Regeneron ...

Add Yahoo as a preferred source to see more of our stories on Google. A bankruptcy judge approved the sale of genetics company 23andMe to a non-profit led by co-founder and former CEO Anne Wojcicki, ...

SAN FRANCISCO, June 30, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a genetics-led consumer healthcare company, today announced that it has received ...

Regeneron has agreed to buy 23andMe, the once buzzy genetic testing company, out of bankruptcy for $256 million under a court-supervised sale process. 23andMe declared bankruptcy in March and ...

Privacy experts are concerned about the risk of "genetic discrimination" after 23andMe, which offered a direct-to-consumer genetic testing service, filed for ...

Add Yahoo as a preferred source to see more of our stories on Google. Millions of people's genetic data may be up for grabs soon. Has yours already been taken? 23andMe, the genetic testing company ...

Anne Wojcicki, cofounder and former CEO of 23andMe, will regain control of the company after her nonprofit, TTAM Research Institute, agreed to purchase nearly all of its assets for $305 million. In ...

Genetic testing company 23andMe isn’t going away, despite declaring bankruptcy. The company and nearly all of its assets, including its biobank of customer genetic samples, have been purchased by ...

A biotech future built on data: Regeneron’s acquisition of 23andMe blurs the line between pharmaceutical innovation and genetic surveillance. Unsplash+ “We are ...

PALO ALTO, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- 23andMe Research Institute, a nonprofit research organization dedicated ...